enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. The 13 Best Eyelash Serums for Thicker, Longer Lashes - AOL

   www.aol.com/lifestyle/13-best-eyelash-serums...

   We spoke with board-certified dermatologists to discover the best-rated eyelash serums for growth. Here are affordable options and formulas for sensitive eyes. The 13 Best Eyelash Serums for ...

3. The 5 Best Eyelash Growth Serums for Longer Lashes - AOL

   www.aol.com/lifestyle/5-best-eyelash-growth...

   For premium support please call: 800-290-4726 more ways to reach us

4. 15 best-selling beauty products you probably didn’t know were ...

   www.aol.com/lifestyle/top-rated-beauty-at-costco...

   Whether you're a longtime Costco shopper or are simply curious about the types of brands you can find at the international retailer, below are 15 best-selling beauty products at Costco that have ...

5. Management of hair loss - Wikipedia

   en.wikipedia.org/wiki/Management_of_hair_loss

   The FP receptor agonist, bimatoprost, in the form of an 0.03% ophthalmic solution termed Latisse, is approved by the US Food and Drug Administration to treat hypotrichosis of the eyelashes, in particular to darken and lengthen eyelashes for cosmetic purposes. [59] Also, bimatoprost may be used to treat small or underdeveloped eyelashes. [60] [61]

6. Bimatoprost - Wikipedia

   en.wikipedia.org/wiki/Bimatoprost

   Bimatoprost is used cosmetically to increase eyelash prominence. Bimatoprost may be used to treat small or underdeveloped eyelashes. [3] [4] The medical term for this is treatment of hypotrichosis; however, the U.S. Food and Drug Administration (FDA) approval is for purely cosmetic purposes (see Prostaglandin F receptor#Clinical significance).

7. Trichomegaly - Wikipedia

   en.wikipedia.org/wiki/Trichomegaly

   Trichomegaly is a condition in which the eyelashes are abnormally long, [1] objectively defined as 12mm or greater in the central area and 8mm in the peripheral. [2] The term was first used by H. Gray in 1944 in a publication in the Stanford Medical Bulletin, [2] though he was only the third person to characterize the disorder; the first two reports were published in German in 1926 and 1931 by ...